NCT02977702View on ClinicalTrials.gov

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

CompletedOBSERVATIONAL

Enrollment

114

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Pancreatic Neoplasms

All Listed Sponsors

lead

Institut de Cancérologie de Lorraine

OTHER

NCT02977702 - Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter